InsiderTrades

Form 4 for RGEN REPLIGEN CORP

Accepted 2022-02-28 00:00:00 ET · period of report 2022-02-24 · accession 0000899243-22-008191 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-02-28 2022-02-24 RGEN Hunt Anthony CEO, Dir F - Tax $189.21 -1,170 195.8K -0.6% -$221.4K
D 2022-02-28 2022-02-24 RGEN Hunt Anthony CEO, Dir A - Grant $0.00 +15.9K 197.0K +9% $0
D 2022-02-28 2022-02-24 RGEN Hunt Anthony CEO, Dir A - Grant $0.00 +20.3K 20.3K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-24 F D 1,170 $189.21 195,825 D — — (F3) Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.
2 Common Common Stock 2022-02-24 A A 15,855 $0.00 196,995 D — — (F1) Mr. Hunt was awarded 15,855 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. (F2) The total reported in Column 5 has been adjusted to correct an overstatement of total holdings by 1,000 shares, first reflected in a Form 5 filed on February 10, 2021.
3 Derivative Stock Option (Right to Buy) 2022-02-24 A A 20,307 $0.00 20,307 D $189.21 · — to 2032-02-24 20,307 Common Stock (F4) One third of the stock options will vest and become exercisable annually on February 24, 2023, February 24, 2024 and February 24, 2025.